Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis

Research output: Contribution to journalComment/debate

Standard

Atopic dermatitis 2017 : where we were 10-15 years ago in psoriasis. / No, Daniel J; Amin, Mina; Egeberg, Alexander; Thyssen, Jacob P; Wu, Jashin J.

In: Journal of Dermatological Treatment, Vol. 29, No. 1, 2018, p. 100-101.

Research output: Contribution to journalComment/debate

Harvard

No, DJ, Amin, M, Egeberg, A, Thyssen, JP & Wu, JJ 2018, 'Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis', Journal of Dermatological Treatment, vol. 29, no. 1, pp. 100-101. https://doi.org/10.1080/09546634.2017.1341606

APA

No, D. J., Amin, M., Egeberg, A., Thyssen, J. P., & Wu, J. J. (2018). Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis. Journal of Dermatological Treatment, 29(1), 100-101. https://doi.org/10.1080/09546634.2017.1341606

Vancouver

No DJ, Amin M, Egeberg A, Thyssen JP, Wu JJ. Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis. Journal of Dermatological Treatment. 2018;29(1):100-101. https://doi.org/10.1080/09546634.2017.1341606

Author

No, Daniel J ; Amin, Mina ; Egeberg, Alexander ; Thyssen, Jacob P ; Wu, Jashin J. / Atopic dermatitis 2017 : where we were 10-15 years ago in psoriasis. In: Journal of Dermatological Treatment. 2018 ; Vol. 29, No. 1. pp. 100-101.

Bibtex

@article{c3d617a05b7a4fe89cd959c32d3d5e8f,
title = "Atopic dermatitis 2017: where we were 10-15 years ago in psoriasis",
abstract = "Novel and innovative treatment options for atopic dermatitis (AD) are underway. The recent advancements in understanding AD are reminiscent of the progress made in psoriasis research over a decade ago.",
keywords = "Antibodies, Monoclonal/therapeutic use, Clinical Trials as Topic, Dermatitis, Atopic/drug therapy, Etanercept/therapeutic use, Humans, Interleukin-13/metabolism, Interleukin-4/metabolism, Psoriasis/drug therapy, Severity of Illness Index, Skin/metabolism, Up-Regulation",
author = "No, {Daniel J} and Mina Amin and Alexander Egeberg and Thyssen, {Jacob P} and Wu, {Jashin J}",
year = "2018",
doi = "10.1080/09546634.2017.1341606",
language = "English",
volume = "29",
pages = "100--101",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Taylor & Francis",
number = "1",

}

RIS

TY - JOUR

T1 - Atopic dermatitis 2017

T2 - where we were 10-15 years ago in psoriasis

AU - No, Daniel J

AU - Amin, Mina

AU - Egeberg, Alexander

AU - Thyssen, Jacob P

AU - Wu, Jashin J

PY - 2018

Y1 - 2018

N2 - Novel and innovative treatment options for atopic dermatitis (AD) are underway. The recent advancements in understanding AD are reminiscent of the progress made in psoriasis research over a decade ago.

AB - Novel and innovative treatment options for atopic dermatitis (AD) are underway. The recent advancements in understanding AD are reminiscent of the progress made in psoriasis research over a decade ago.

KW - Antibodies, Monoclonal/therapeutic use

KW - Clinical Trials as Topic

KW - Dermatitis, Atopic/drug therapy

KW - Etanercept/therapeutic use

KW - Humans

KW - Interleukin-13/metabolism

KW - Interleukin-4/metabolism

KW - Psoriasis/drug therapy

KW - Severity of Illness Index

KW - Skin/metabolism

KW - Up-Regulation

U2 - 10.1080/09546634.2017.1341606

DO - 10.1080/09546634.2017.1341606

M3 - Comment/debate

C2 - 28604121

VL - 29

SP - 100

EP - 101

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 1

ER -

ID: 215785496